Publication: Synthesis and cytotoxicity of novel N-sulfonyl-1,2,3,4- tetrahydroisoquinoline thiosemicarbazone derivatives
| dc.contributor.author | Pingaew R. | |
| dc.contributor.author | Prachayasittikul S. | |
| dc.contributor.author | Ruchirawat S. | |
| dc.contributor.author | Prachayasittikul V. | |
| dc.date.accessioned | 2021-04-05T03:33:23Z | |
| dc.date.available | 2021-04-05T03:33:23Z | |
| dc.date.issued | 2013 | |
| dc.date.issuedBE | 2556 | |
| dc.description.abstract | The modified Pictet-Spengler reaction of phenylethylbenzene sulfonamide with a commercially available glyoxal to construct 1-benzoyl- and 1-acetyl-1,2,3,4-tetrahydroisoquinolines 9a-n has been reported. The reaction could be accomplished, regardless of the oxygenation pattern on the aromatic ring, leading to the N-sulfonyltetrahydroisoquinoline analogs which are versatile intermediates for the synthesis of new thiosemicarbazone analogs of 1,2,3,4-tetrahydroisoquinoline. Bioactivity test revealed that most thiosemicarbazones displayed cytotoxic potency against MOLT-3 cell lines with an IC50 less than 20 μg/mL. Significantly, the thiosemicarbazone analog of 1-acetyltetrahydroisoquinoline 9j was the most potent cytotoxic compound against HuCCA-1, HepG2, and MOLT-3 cells. This study provides the novel lead molecules for further development. © 2012 Springer Science+Business Media, LLC. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Medicinal Chemistry Research. Vol 22, No.1 (2013), p.267-277 | |
| dc.identifier.doi | 10.1007/s00044-012-0025-y | |
| dc.identifier.issn | 10542523 | |
| dc.identifier.other | 2-s2.0-84872013061 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/6792 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | 1 acetyl 6,7 dimethoxy n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 acetyl 6,7 dimethoxy n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 acetyl n 3 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 acetyl n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 acetyl n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl 6,7 dimethoxy n 4 chlorobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl 6,7 dimethoxy n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl 6,7 dimethoxy n 4 methylbenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl 6,7 dimethoxy n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl n 4 methylbenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | 1 benzoyl n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
| dc.subject.other | Antineoplastic agent | |
| dc.subject.other | Doxorubicin | |
| dc.subject.other | Etoposide | |
| dc.subject.other | Thiosemicarbazone derivative | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Antineoplastic activity | |
| dc.subject.other | Article | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Cytotoxicity | |
| dc.subject.other | Drug activity | |
| dc.subject.other | Drug potency | |
| dc.subject.other | Drug synthesis | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | IC 50 | |
| dc.subject.other | Oxygenation | |
| dc.subject.other | Pictet Spengler reaction | |
| dc.title | Synthesis and cytotoxicity of novel N-sulfonyl-1,2,3,4- tetrahydroisoquinoline thiosemicarbazone derivatives | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872013061&doi=10.1007%2fs00044-012-0025-y&partnerID=40&md5=d4d999d10fb45e5c51532ddca15824f7 |
